1. Home
  2. TNXP vs ISPO Comparison

TNXP vs ISPO Comparison

Compare TNXP & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • ISPO
  • Stock Information
  • Founded
  • TNXP 2007
  • ISPO 2010
  • Country
  • TNXP United States
  • ISPO United States
  • Employees
  • TNXP N/A
  • ISPO N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • ISPO Blank Checks
  • Sector
  • TNXP Health Care
  • ISPO Finance
  • Exchange
  • TNXP Nasdaq
  • ISPO Nasdaq
  • Market Cap
  • TNXP 272.0M
  • ISPO 44.3M
  • IPO Year
  • TNXP N/A
  • ISPO N/A
  • Fundamental
  • Price
  • TNXP $40.87
  • ISPO $3.52
  • Analyst Decision
  • TNXP Strong Buy
  • ISPO
  • Analyst Count
  • TNXP 2
  • ISPO 0
  • Target Price
  • TNXP $585.00
  • ISPO N/A
  • AVG Volume (30 Days)
  • TNXP 720.8K
  • ISPO 35.6K
  • Earning Date
  • TNXP 08-15-2025
  • ISPO 08-12-2025
  • Dividend Yield
  • TNXP N/A
  • ISPO N/A
  • EPS Growth
  • TNXP N/A
  • ISPO N/A
  • EPS
  • TNXP N/A
  • ISPO N/A
  • Revenue
  • TNXP $10,041,000.00
  • ISPO $265,499,000.00
  • Revenue This Year
  • TNXP $11.66
  • ISPO N/A
  • Revenue Next Year
  • TNXP $793.18
  • ISPO $148.67
  • P/E Ratio
  • TNXP N/A
  • ISPO N/A
  • Revenue Growth
  • TNXP N/A
  • ISPO N/A
  • 52 Week Low
  • TNXP $6.76
  • ISPO $3.11
  • 52 Week High
  • TNXP $130.00
  • ISPO $9.31
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 62.15
  • ISPO 45.87
  • Support Level
  • TNXP $33.20
  • ISPO $3.45
  • Resistance Level
  • TNXP $43.80
  • ISPO $3.87
  • Average True Range (ATR)
  • TNXP 2.63
  • ISPO 0.37
  • MACD
  • TNXP 0.31
  • ISPO -0.02
  • Stochastic Oscillator
  • TNXP 77.43
  • ISPO 17.41

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About ISPO Inspirato Incorporated

Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.

Share on Social Networks: